ANKRD57 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.429400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.427400E-01
Normal-vs-Stage2
3.451400E-01
Normal-vs-Stage3
5.340200E-01
Normal-vs-Stage4
4.146500E-02
Stage1-vs-Stage2
7.480400E-01
Stage1-vs-Stage3
9.332000E-01
Stage1-vs-Stage4
9.229600E-02
Stage2-vs-Stage3
7.290800E-01
Stage2-vs-Stage4
1.507810E-01
Stage3-vs-Stage4
1.789820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.497600E-01
Normal-vs-AfricanAmerican
2.703600E-01
Normal-vs-Asian
3.321800E-01
Caucasian-vs-AfricanAmerican
9.817400E-01
Caucasian-vs-Asian
1.450220E-01
AfricanAmerican-vs-Asian
3.932400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.559400E-01
Normal-vs-Female
2.475600E-01
Male-vs-Female
9.964100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.081200E-01
Normal-vs-Age(41-60Yrs)
3.455400E-01
Normal-vs-Age(61-80Yrs)
2.955400E-01
Normal-vs-Age(81-100Yrs)
1.911350E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.889200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.699200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.722200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.118410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.949900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.473000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.633600E-01
Normal-vs-Daily Drinker
2.677200E-01
Normal-vs-Weekly Drinker
1.794440E-01
Normal-vs-Occasional Drinker
1.044590E-01
Normal-vs-Social Drinker
3.539400E-01
Non Drinker-vs-Daily Drinker
1.152630E-01
Non Drinker-vs-Weekly Drinker
1.736180E-01
Non Drinker-vs-Occasional Drinker
5.279700E-02
Non Drinker-vs-Social Drinker
7.270800E-01
Daily Drinker-vs-Weekly Drinker
7.360800E-01
Daily Drinker-vs-Occasional Drinker
9.612400E-01
Daily Drinker-vs-Social Drinker
2.700800E-01
Weekly Drinker-vs-Occasional Drinker
7.037000E-01
Weekly Drinker-vs-Social Drinker
3.591800E-01
Occasional Drinker-vs-Social Drinker
1.665410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.984990E-01
Normal-vs-Grade 2
1.925970E-01
Normal-vs-Grade 3
6.105800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.597900E-03
Grade 1-vs-Grade 3
1.491930E-02
Grade 1-vs-Grade 4
1.984990E-01
Grade 2-vs-Grade 3
6.728600E-01
Grade 2-vs-Grade 4
1.925970E-01
Grade 3-vs-Grade 4
6.105800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.998600E-01
Normal-vs-NonDiabetic
4.083400E-01
Diabetic-vs-NonDiabetic
5.282000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.393200E-01
Normal-vs-NoPancreatitis
3.878000E-01
Pancreatitis-vs-NoPancreatitis
8.281600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.621400E-01
Normal-vs-N1
3.494600E-01
N0-vs-N1
2.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.540700E-03
Normal-vs-TP53-NonMutant
5.885600E-01
TP53-Mutant-vs-TP53-NonMutant
2.215000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
